Effects of steroidal and nonsteroidal aromatase inhibitors on markers of bone turnover in healthy postmenopausal women
2007

Effects of Aromatase Inhibitors on Bone Health in Postmenopausal Women

Sample size: 84 publication 10 minutes Evidence: moderate

Author Information

Author(s): Goss Paul E, Hadji Peyman, Subar Milayna, Abreu Paula, Thomsen Torben, Banke-Bochita Jose

Primary Institution: Massachusetts General Hospital

Hypothesis

This study was designed to compare the effects of exemestane with the nonsteroidal aromatase inhibitors anastrozole and letrozole on serum and urine levels of biomarkers of bone turnover in healthy postmenopausal women.

Conclusion

Exemestane increased serum levels of the bone-formation marker PINP after 24 weeks, suggesting a specific bone-formation effect related to its androgenic structure.

Supporting Evidence

  • Exemestane treatment resulted in a significant increase in the bone-formation marker PINP compared to other treatments.
  • Bone-resorption markers increased in all treatment groups, but the increase was lower for anastrozole.
  • Exemestane was the only aromatase inhibitor that consistently increased levels of PINP.

Takeaway

This study looked at how different medications for breast cancer affect bones in older women. It found that one medicine, exemestane, helps bones more than the others.

Methodology

The study involved 84 healthy postmenopausal women who were randomized to receive exemestane, letrozole, anastrozole, or placebo for 24 weeks, with assessments of bone turnover markers at various time points.

Potential Biases

Potential bias due to the exploratory nature of the study and the small sample size.

Limitations

The study had a small sample size and was of short duration, which may limit the generalizability of the findings.

Participant Demographics

All participants were white women aged 50 to 75 years who had experienced natural menopause.

Statistical Information

P-Value

0.024

Confidence Interval

95% CI, 11–30%

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1757

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication